23andMe Is Selling All User Data to Drug Developer Regeneron todayheadline
Genetic testing startup 23andMe, which filed for bankruptcy earlier this year, announced on Monday that it has agreed to sell ...
Read moreDetailsTag: Regeneron
Regeneron is buying 23andMe out of bankruptcy for $256 million todayheadline
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
Read moreDetailsRegeneron Pharma’s first-quarter results miss on lower Eylea demand
(Reuters) -Regeneron missed Wall Street estimates for first-quarter results on Tuesday, hurt by waning demand for its blockbuster eye disease ...
Read moreDetails
